Market has been very wobbly as of late. From what I've read from various brokers, ADH's EBIT guidance is 5% below Goldman Sach's forecast and 8% below Morgans' forecast. Sales revenue was actually in line with forecast. So a 20% decline in share price vs a max 10% downgrade in EBIT suggests to me the stock was oversold.
Also, I dont think COVID related/store closure costs would be included in the DCF calculation cos they are one-off most likely. So at current share price, assuming 2H22 will be $32m as well i.e. flat, ADH is trading at 8x EBIT and 5x normalised EBIT. This also leaves room for potential upside assuming there is no lockdown this year.
- Forums
- ASX - By Stock
- Ann: ADH Trading Update
Market has been very wobbly as of late. From what I've read from...
-
-
- There are more pages in this discussion • 36 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add ADH (ASX) to my watchlist
(20min delay)
|
|||||
Last
$2.32 |
Change
-0.040(1.69%) |
Mkt cap ! $407.9M |
Open | High | Low | Value | Volume |
$2.36 | $2.38 | $2.29 | $1.433M | 617.3K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 2866 | $2.30 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$2.33 | 12866 | 2 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 2866 | 2.300 |
1 | 2866 | 2.290 |
3 | 4117 | 2.280 |
1 | 1031 | 2.270 |
2 | 2491 | 2.260 |
Price($) | Vol. | No. |
---|---|---|
2.330 | 12866 | 2 |
2.340 | 2866 | 1 |
2.350 | 4866 | 2 |
2.360 | 7048 | 3 |
2.370 | 21000 | 1 |
Last trade - 16.10pm 21/10/2024 (20 minute delay) ? |
Featured News
ADH (ASX) Chart |
The Watchlist
LGP
LITTLE GREEN PHARMA LTD
Paul Long, Chief Executive Officer
Paul Long
Chief Executive Officer
SPONSORED BY The Market Online